Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02511444 · ClinicalTrials.gov registry record · NA

Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor

A NA study, sponsored by MemorialCare Health System.

Completed
Registry status
NA
Development phase
342
Enrollment target

NCT02511444 is a NA study that has completed, run by MemorialCare Health System. The registered enrollment target is 342 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02511444, a NA study, has completed, sponsored by MemorialCare Health System.

COMPLETED
Registry status
NA
Development phase
342 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the test characteristics of a rapid intrapartum real- time polymerase chain reaction (RT-PCR) compared to the intrapartum GBS culture as the standard in preterm patients presenting with threatened preterm labor or with obstetric indications for preterm delivery.

Interventions

  • OTHER GBS culture and real time PCR

Trial Details

FieldValue
Enrollment Target 342 participants
Start Date 2015-07
Est. Completion 2019-12
Phase NA

Sponsor

MemorialCare Health System

21 total trials

What the Registry Record Tells You About NCT02511444

The ClinicalTrials.gov registry entry for NCT02511444 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 342 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MemorialCare Health System, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which GBS culture and real time PCR is the first listed.

NCT02511444 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02511444 about?

NCT02511444 is a clinical study titled "Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor". The purpose of this study is to evaluate the test characteristics of a rapid intrapartum real- time polymerase chain reaction (RT-PCR) compared to the intrapartum GBS culture as the standard in preterm patients presenting with threatened preterm labor or with obstetric indications for preterm delive...

What is the current status of trial NCT02511444?

This trial is currently completed. It is a NA study. The enrollment target is 342 participants. The study started on 2015-07. Estimated completion is 2019-12.

What interventions are being tested in trial NCT02511444?

The interventions under investigation include: GBS culture and real time PCR (OTHER).

Who is sponsoring clinical trial NCT02511444?

This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.